多药丸疗法用于心血管疾病预防和联合药物治疗治疗高血压管理
Keisuke Narita1, Satoshi Hoshide1, Kazuomi Kario1
1Division of Cardiovascular Medicine, Department of Internal Medicine, Jichi Medical University School of Medicine, Shimotsuke 329-0498, Japan.
Journal of clinical medicine
|December 9, 2023
概括
多药丸策略,将多种药物结合在一片药片中,为预防心血管疾病提供了一个有前途的解决方案. 这些组合药片可以改善药物服药,并有效治疗高血压.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 心血管疾病预防指导方针已经建立,但最佳的药物治疗往往是由于药物坚持不良和临床惯性而受到阻碍.
- 多药丸策略,定义为与三种或更多药物的组合药片,越来越多地被认为是预防心血管疾病的有用性.
- 标准多药剂通常包括抗血小板剂,抗高血压剂和他类药物,解决心血管事件的关键风险因素.
研究的目的:
- 审查支持用于预防心血管疾病的多药药剂策略的证据.
- 讨论组合抗高血压治疗的作用,包括新药,在管理高血压.
- 探索多药药在克服药物坚持和临床惯性方面的挑战方面的潜力.
主要方法:
- 对预防心血管疾病的多药药策略研究的文献综述.
- 对联合抗高血压疗法的指导方针和研究进行分析.
- 在多药药开发的背景下讨论像RNAI和SGLT2i这样的新兴药物.
主要成果:
- 含有抗血小板剂,抗高血压剂和他类药物的多药丸在预防心血管疾病方面已经证明有用.
- 组合抗高血压药片,特别是那些含有氨酸-血管新生素系统抑制剂和利尿剂或通道阻塞剂的药片,有效降低血压.
- 新型药物为扩展的多药剂配方提供了潜在的潜力,以解决诸如心力衰竭和糖尿病等复杂疾病.
结论:
- 多种药丸策略是一种可行的方法,可以提高药物坚持性和改善心血管疾病预防结果.
- 多药组合疗法在高血压管理中是有效的,与指南建议保持一致.
- 未来的多药丸开发,包括新的药物类别,可能进一步优化心血管风险管理,并解决多药学挑战.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
526
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
526
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
174
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
174
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
667
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
667
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45


